These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 17513019

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacophore modeling, 3D-QSAR studies, and in-silico ADME prediction of pyrrolidine derivatives as neuraminidase inhibitors.
    Zhang J, Pan X, Wang C, Wang F, Li P, Xu W, He L.
    Chem Biol Drug Des; 2012 Mar; 79(3):353-9. PubMed ID: 22222003
    [Abstract] [Full Text] [Related]

  • 23. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
    Andrade CH, Pasqualoto KF, Ferreira EI, Hopfinger AJ.
    J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716
    [Abstract] [Full Text] [Related]

  • 24. Quantitative structure activity relationship of benzoxazinone derivatives as neuropeptide Y Y5 receptor antagonists.
    Deswal S, Roy N.
    Eur J Med Chem; 2006 Apr; 41(4):552-7. PubMed ID: 16545499
    [Abstract] [Full Text] [Related]

  • 25. Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions.
    Abu Hammad AM, Afifi FU, Taha MO.
    J Mol Graph Model; 2007 Sep; 26(2):443-56. PubMed ID: 17360207
    [Abstract] [Full Text] [Related]

  • 26. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
    Mitrasinovic PM.
    Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Influenza virus neuraminidase: structure, antibodies, and inhibitors.
    Colman PM.
    Protein Sci; 1994 Oct; 3(10):1687-96. PubMed ID: 7849585
    [Abstract] [Full Text] [Related]

  • 30. Quantitative structure-activity relationship studies on 2-amino-6-arylsulfonylbenzonitriles as human immunodeficiency viruses type 1 reverse transcriptase inhibitors using descriptors obtained from substituents and whole molecular structures.
    Hemmateenejad B, Sabet R, Fassihi A.
    Chem Biol Drug Des; 2009 Oct; 74(4):405-15. PubMed ID: 19691465
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS, Roy K.
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [Abstract] [Full Text] [Related]

  • 33. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
    Du QS, Huang RB, Wei YT, Du LQ, Chou KC.
    J Comput Chem; 2008 Jan 30; 29(2):211-9. PubMed ID: 17559075
    [Abstract] [Full Text] [Related]

  • 34. Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors.
    Yi X, Guo Z, Chu FM.
    Bioorg Med Chem; 2003 Apr 03; 11(7):1465-74. PubMed ID: 12628672
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ketones as building blocks for dynamic combinatorial libraries: highly active neuraminidase inhibitors generated via selection pressure of the biological target.
    Hochgürtel M, Biesinger R, Kroth H, Piecha D, Hofmann MW, Krause S, Schaaf O, Nicolau C, Eliseev AV.
    J Med Chem; 2003 Jan 30; 46(3):356-8. PubMed ID: 12540234
    [Abstract] [Full Text] [Related]

  • 38. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities.
    Liu AL, Wang HD, Lee SM, Wang YT, Du GH.
    Bioorg Med Chem; 2008 Aug 01; 16(15):7141-7. PubMed ID: 18640042
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. QSAR study of heparanase inhibitors activity using artificial neural networks and Levenberg-Marquardt algorithm.
    Jalali-Heravi M, Asadollahi-Baboli M, Shahbazikhah P.
    Eur J Med Chem; 2008 Mar 01; 43(3):548-56. PubMed ID: 17602800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.